Prescription Drug Makers Have Not Begun Many Pending Post-Market Studies On Newly Approved Drugs, FDA Says

... Prescription drug companies as of Sept. 30, 2006, have not begun 71% of post-approval studies that were promised as a condition of FDA approval of a drug, according to an annual FDA report released on Thursday, Bloomberg/Long Island Newsday reports. Drug makers often agree to conduct post-market studies of safety, dosage and other factors of a drug to receive FDA approval. [click link for full article] ...